215 related articles for article (PubMed ID: 12072577)
1. Prejunctional and postjunctional inhibitory actions of eprosartan and candesartan in the isolated rabbit mesenteric artery.
Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA
J Cardiovasc Pharmacol; 2002 Jul; 40(1):50-7. PubMed ID: 12072577
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of facilitation of sympathetic neurotransmission and angiotensin II-induced pressor effects in the pithed rat: comparison between valsartan, candesartan, eprosartan and embusartan.
Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
J Hypertens; 2001 Dec; 19(12):2241-50. PubMed ID: 11725169
[TBL] [Abstract][Full Text] [Related]
3. Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery.
Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA
J Cardiovasc Pharmacol; 2001 Jul; 38(1):141-8. PubMed ID: 11444497
[TBL] [Abstract][Full Text] [Related]
4. Pre- and postsynaptic inhibitory potencies of the angiotensin AT1 receptor antagonists eprosartan and candesartan.
Nap A; Mathy MJ; Balt JC; Pfaffendorf M; van Zwieten PA
Eur J Pharmacol; 2003 May; 469(1-3):117-24. PubMed ID: 12782193
[TBL] [Abstract][Full Text] [Related]
5. Different prejunctional and postjunctional responses to angiotensin II and AT1-receptor inhibition: influence of maturation.
Nap A; Mathy MJ; Pfaffendorf M; van Zwieten PA
J Cardiovasc Pharmacol; 2004 Mar; 43(3):432-9. PubMed ID: 15076228
[TBL] [Abstract][Full Text] [Related]
6. Decreased facilitation by angiotensin II of noradrenergic neurotransmission in isolated mesenteric artery of rabbits with chronic heart failure.
Balt JC; Belterman CN; Mathy MJ; Nap A; Baartscheer A; Pfaffendorf M; Van Zwieten PA
J Cardiovasc Pharmacol; 2003 Mar; 41(3):356-62. PubMed ID: 12605013
[TBL] [Abstract][Full Text] [Related]
7. Impaired neuronal and vascular responses to angiotensin II in a rabbit congestive heart failure model.
Nap A; Belterman CN; Mathy MJ; Balt JC; Pfaffendorf M; van Zwieten PA
J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):220-7. PubMed ID: 14689369
[TBL] [Abstract][Full Text] [Related]
8. Sympatho-inhibitory properties of various AT1 receptor antagonists.
Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
J Hypertens Suppl; 2002 Jun; 20(5):S3-11. PubMed ID: 12184061
[TBL] [Abstract][Full Text] [Related]
9. AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade.
Widdop RE; Matrougui K; Levy BI; Henrion D
Hypertension; 2002 Oct; 40(4):516-20. PubMed ID: 12364356
[TBL] [Abstract][Full Text] [Related]
10. Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR.
Touyz RM; Endemann D; He G; Li JS; Schiffrin EL
Hypertension; 1999 Jan; 33(1 Pt 2):366-72. PubMed ID: 9931131
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of eprosartan and losartan at prejunctional angiotensin II receptors.
Guimarães S; Pinheiro H; Tavares P; Loio A; Moura D
Naunyn Schmiedebergs Arch Pharmacol; 2001 May; 363(5):509-14. PubMed ID: 11383711
[TBL] [Abstract][Full Text] [Related]
12. Sympatho-inhibitory actions of irbesartan in pithed spontaneously hypertensive and Wistar-Kyoto rats.
Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
Fundam Clin Pharmacol; 2003 Feb; 17(1):83-91. PubMed ID: 12588634
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic differences of various AT1-receptor blockers in isolated vessels of different origin.
Morsing P; Adler G; Brandt-Eliasson U; Karp L; Ohlson K; Renberg L; Sjöquist PO; Abrahamsson T
Hypertension; 1999 Jun; 33(6):1406-13. PubMed ID: 10373224
[TBL] [Abstract][Full Text] [Related]
14. A comparison of AT1 angiotensin II antagonists at pre- and postjunctional angiotensin II receptors of the rat tail artery.
Pinheiro H; Moura D; Albino-Teixeira A; Alves C; Torres L; Guimarães S
Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):537-42. PubMed ID: 12444494
[TBL] [Abstract][Full Text] [Related]
15. Enhancement by exogenous and locally generated angiotensin II of purinergic neurotransmission via angiotensin type 1 receptor in the guinea-pig isolated mesenteric artery.
Onaka U; Fujii K; Abe I; Fujishima M
Br J Pharmacol; 1997 Nov; 122(5):942-8. PubMed ID: 9384513
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II receptors involved in the enhancement of noradrenergic transmission in the caudal artery of the spontaneously hypertensive rat.
Cox SL; Story DF; Ziogas J
Br J Pharmacol; 1996 Nov; 119(5):965-75. PubMed ID: 8922747
[TBL] [Abstract][Full Text] [Related]
17. Direct effects of candesartan and eprosartan on human cloned potassium channels involved in cardiac repolarization.
Caballero R; Delpón E; Valenzuela C; Longobardo M; González T; Tamargo J
Mol Pharmacol; 2001 Apr; 59(4):825-36. PubMed ID: 11259627
[TBL] [Abstract][Full Text] [Related]
18. Different AT1 receptor subtypes at pre- and postjunctional sites: AT1A versus AT1B receptors.
Nap A; Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
J Cardiovasc Pharmacol; 2004 Jan; 43(1):14-20. PubMed ID: 14668562
[TBL] [Abstract][Full Text] [Related]
19. Peripheral sympatholytic actions of four AT1 antagonists: are they relevant for long-term antihypertensive efficacy?
Dendorfer A; Dominiak P; Tempel K; Raasch W
J Hypertens; 2005 Oct; 23(10):1861-7. PubMed ID: 16148610
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of sympathetic outflow by the angiotensin II receptor antagonist, eprosartan, but not by losartan, valsartan or irbesartan: relationship to differences in prejunctional angiotensin II receptor blockade.
Ohlstein EH; Brooks DP; Feuerstein GZ; Ruffolo RR
Pharmacology; 1997 Nov; 55(5):244-51. PubMed ID: 9399334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
